Literature DB >> 33926485

Modulation of steroidogenesis by Actaea racemosa and vitamin C combination, in letrozole induced polycystic ovarian syndrome rat model: promising activity without the risk of hepatic adverse effect.

Asmaa A Azouz1, Sara E Ali2, Reham M Abd-Elsalam3, Shimaa R Emam4, Mona K Galal5, Sherif H Elmosalamy2, Muhammed A Alsherbiny6,7, Bardes B Hassan3, Chun Guang Li8, Shymaa A El Badawy1.   

Abstract

BACKGROUND: Complementary remedies such as the Chinese herb 'Sheng Ma' (Black cohosh; Actaea racemosa 'AR') are being sought to overcome the shortcomings of conventional hormonal and surgical therapies developed for the treatment of polycystic ovary syndrome (PCOS). However, AR-induced hepatotoxicity necessitates a cautionary warning to be labeled on its products as recommended by the United States Pharmacopeia, where four out of seven hepatotoxic cases in Sweden were possibly associated with black cohosh products.
METHODS: We investigated the effects, safety, and molecular targets of black cohosh ethanolic extract and/or vitamin C on ovarian functionality and oxidative response in hyperandrogenism-induced PCOS rats. A well-established rat model using oral letrozole, daily, for 21 days was employed. The rats then received the AR extract with and without vitamin C for 28 days. The hormonal evaluation, antioxidant status, histopathological examination, immunohistochemical analysis, cell proliferation, and the expression ratio of the aromatase (Cyp19α1) gene were evaluated. Additionally, holistic profiling of the AR arsenal of secondary metabolites was performed using ultra-high-performance liquid chromatography (UHPLC) coupled with quadrupole high-resolution time of flight mass spectrometry (QTOF-MS).
RESULTS: Beneficial effects were exerted by AR in PCOS rats as antioxidant status, hormonal profile, lipid profile, glucose level, liver functions, and the induced Ki-67 expression in the granulosa, theca cell layers and interstitial stromal cells were all improved. Notably, the combination of AR with vitamin C was not only more effective in reversing the dysregulated levels of testosterone, luteinizing hormone, and mRNA level of Cyp19α1 gene in the PCOS rat, but also safer. The combination regulated both ovarian and hepatic malondialdehyde (MDA) and glutathione (GSH) levels with histological improvement observed in the liver and ovaries. In addition, the untargeted metabolomic profiling enabled the identification of 61 metabolites allocated in five major chemical classes.
CONCLUSION: This study demonstrated the benefit of the combinatorial effects of AR and vitamin C in mitigating the reproductive and metabolic disorders associated with PCOS with the elimination of AR hepatotoxic risk.

Entities:  

Keywords:  Actaea racemosa; Hepatotoxicity; Metabolomic profiling; PCOS rat model; Polycystic ovarian syndrome; UPLC-QTOF-MS; Vitamin C

Year:  2021        PMID: 33926485     DOI: 10.1186/s13020-021-00444-z

Source DB:  PubMed          Journal:  Chin Med        ISSN: 1749-8546            Impact factor:   5.455


  68 in total

1.  Kami-shoyo-san, Kampo (Japanese traditional medicine), is effective for climacteric syndrome, especially in hormone-replacement-therapy-resistant patients who strongly complain of psychological symptoms.

Authors:  Takao Hidaka; Rika Yonezawa; Shigeru Saito
Journal:  J Obstet Gynaecol Res       Date:  2012-07-06       Impact factor: 1.730

Review 2.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

3.  Comparison of "selective" opiate receptor antagonists on the isolated mouse vas deferens.

Authors:  C B Smith; L Bennett-Kelly; J H Woods
Journal:  Neuropeptides       Date:  1984-12       Impact factor: 3.286

4.  Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations.

Authors:  Amanda Ladrón de Guevara; Carolina Fux-Otta; Nicolás Crisosto; Paula Szafryk de Mereshian; Bárbara Echiburú; Gabriel Iraci; Francisco Perez-Bravo; Teresa Sir-Petermann
Journal:  Fertil Steril       Date:  2014-03-22       Impact factor: 7.329

5.  The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment.

Authors:  Carrie C Dennett; Judy Simon
Journal:  Diabetes Spectr       Date:  2015-05

Review 6.  Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  John A Barry; Mallika M Azizia; Paul J Hardiman
Journal:  Hum Reprod Update       Date:  2014-03-30       Impact factor: 15.610

7.  Therapeutic Effect of Ecklonia cava Extract in Letrozole-Induced Polycystic Ovary Syndrome Rats.

Authors:  Hyun Yang; Seung Yeon Lee; Sang R Lee; Bo-Jeong Pyun; Hye Jin Kim; Young Ho Lee; Sun Woo Kwon; Dong Ho Suh; Choong Hwan Lee; Eui-Ju Hong; Hye Won Lee
Journal:  Front Pharmacol       Date:  2018-11-19       Impact factor: 5.810

8.  Syzygium cumini (L.) Skeels improves metabolic and ovarian parameters in female obese rats with malfunctioning hypothalamus-pituitary-gonadal axis.

Authors:  R O A Benevides; C C Vale; J L L Fontelles; L M França; T S Teófilo; S N Silva; A M A Paes; R S Gaspar
Journal:  J Ovarian Res       Date:  2019-02-04       Impact factor: 4.234

9.  Effect of the aqueous extract of Foeniculum vulgare (fennel) on the kidney in experimental PCOS female rats.

Authors:  Somayyeh Sadrefozalayi; Farah Farokhi
Journal:  Avicenna J Phytomed       Date:  2014-03

Review 10.  Selective estrogen receptor modulators: tissue specificity and clinical utility.

Authors:  Stephen Martinkovich; Darshan Shah; Sonia Lobo Planey; John A Arnott
Journal:  Clin Interv Aging       Date:  2014-08-28       Impact factor: 4.458

View more
  1 in total

Review 1.  Medicinal plants' proposed nanocomposites for the management of endocrine disorders.

Authors:  Raghdaa Hamdan Al Zarzour; Ezatul Ezleen Kamarulzaman; Fadi G Saqallah; Fauziahanim Zakaria; Muhammad Asif; Khairul Niza Abdul Razak
Journal:  Heliyon       Date:  2022-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.